Dr Lal Path Labs Q2 net profit dips 4 percent at Rs 50.9 crore
New Delhi: Diagnostic chain Dr. Lal Path Labs reported a 3.96 percent dip in its consolidated net profit to Rs 50.9 crore for the September quarter of the current fiscal.
The company had posted a net profit of Rs 53 crore for the corresponding period of the previous fiscal, Dr. Lal PathLabs said in a BSE filing.
Consolidated revenue from operations of the company rose to Rs 278.1 crore for the quarter under consideration as against Rs 262.2 crore for the same period a year ago.
The board of the company has recommended an interim dividend of Rs 1.50 per equity share of Rs 10 each, Dr. Lal PathLabs said.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd